Udveje Behandling Aps: Financial statements 2021
CVR: 40518916
Source: annual report 2021, Danish Business Authority
01/10/2020 – 30/09/2021
Udveje Behandling Aps (CVR 40518916) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,066,649 and a net result of DKK 222,294. Equity in the 2021 report amounted to DKK 207,715. The solvency ratio was 48.8%.
- Gross Profit
- DKK 1,066,649
- Profit/Loss
- DKK 222,294
- Equity
- DKK 207,715
- Total Assets
- DKK 425,554
Official annual report
Find more companies like Udveje Behandling Aps
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Udveje Behandling Aps has published its interim report for the period May 14, 2019 to September 30, 2020.
On January 29, 2021, the company changed its name from Udveje ApS to Udveje Behandling Aps.
About Udveje Behandling Aps
Udveje Behandling Aps is a Danish company of the type Anpartsselskab based in Store Merløse, founded in 2019. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named Udveje ApS. The management consists of John Kastrup. The board consists of Rolf Nolsøe Bau (chair), Chit Calopez Lodberg, Claus Christiansen and Kirsten Benediktson. The company is owned by UDVEJE Holding ApS. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 4,937,535 and a net result of DKK 64,996 compared with DKK 541,297 the year before. Equity in the 2025 report amounted to DKK 675,868.